People · Operator
Named in public records as an officer, director or promoter · active 2017–2020 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| TELA Bio, Inc. | — | Biotechnology | Series C | $104.8M | $435.1M | 2017 |
| Squid Ink, Inc. | — | Other Health Care | Series B | $30.2M | $620.8M | 2020 |
Ashley Friedman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ashley Friedman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Christopher Smith | 1 | 15 |
| Adele Oliva | 1 | 9 |
| Kevin Rakin | 1 | 7 |
| Adele C. Oliva | 1 | 5 |
| Matt Zuga | 1 | 4 |
| Jeff Thomas | 1 | 4 |
| Paul Touhey | 1 | 3 |
| Yuriy Prilutskiy | 1 | 3 |
| Kurt Azarbarzin | 1 | 3 |
| Antony Koblish | 1 | 3 |
| Vince Burgess | 1 | 3 |
| Ashley C. Friedman | 1 | 1 |
| Paul C. Touhey | 1 | 1 |
| Jerry Liao | 1 | 1 |
| Nora J. Brennan | 1 | 1 |
| Ronald J. Ellis, Jr. | 1 | 1 |
| Kurt Ararbarzin | 1 | 1 |
| Christoper Smith | 1 | 1 |
| Vince Burgass | 1 | 1 |
| Ashley Freidman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.